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Patients with schizophrenia and alcohol dependence are often smokers. There are inconsistencies 
across the literature data on the relationship between the functional catechol-O-methyl-
transferase (COMT) Val108/158Met polymorphism and smoking and/or nicotine dependence 
(Redden et al., 2005; Tammimaki and Mannisto, 2010).  
The study elucidated the association between the COMT Val108/158Met polymorphism and 
smoking in 828 ethnically homogenous non-related Caucasian patients with schizophrenia 
(40.3±12.6 years old), 616 patients with alcohol dependence (49.7±10.2 years old), diagnosed 
using a Structured Clinical Interview based on DSM-IV criteria, and in 1058 healthy control 
subjects (40.5±15.3 years old). The COMT Val108/158Met polymorphism was genotyped using 
a Taqman-based allele-specific polymerase chain reaction assay (Applied Biosystems, Foster 
City, CA, USA).  
COMT genotypes in the studied groups were in the Hardy-Weinberg equilibrium. The present 
smoking status differed significantly (χ
2
=327.71; P<0.001) between the studied groups, since 
male schizophrenic patients smoked more frequently, while healthy control women smoked less 
frequently than other subjects. The stepwise logistic regression (OR=1.56, 95% CI=1.10-2.23, 
P=0.014) and the χ
2 
test (Table 1) revealed that COMT Val/Val genotype was significantly 
associated with smoking in healthy male subjects, since carriers of one (χ
2
=5.686; P=0.017) or 
two (χ
2
=9.783; P=0.008) Val alleles were more frequently current smokers.  
The significant association between smoking, age and gender, with no interaction between 
smoking and COMT Val108/158Met variants in patients with schizophrenia and alcohol 
dependence might be explained by the different effects of nicotine on social and interpersonal 
factors in mental versus healthy subjects, or by the different interactions between dopamine 
activity and nicotine in the regions involved in the regulation of the reward pathways in healthy 
opposed to subjects with schizophrenia and alcohol dependence. Although the hypothesis of the 
study was that COMT Val108/158Met genotypes will be significantly associated with smoking 
in schizophrenia and alcohol dependence, our study, with sufficiently large sample size 
(N=2502) and power (higher than 0.800), matched for ethnicity and gender, showed for the first 
time the lack of significant association between smoking and COMT Val108/158Met 
polymorphism in schizophrenia, and confirmed no association between smoking and COMT 
Val108/158Met in alcoholism (Foroud et al., 2007). In line with previous results obtained in 
smaller groups (Nedic et al., 2010), COMT Val108/158Met polymorphism was significantly 
   
 
associated with smoking in healthy male subjects, due to the over-representation of the Val/Val 
genotype in healthy male current smokers.  
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Table 1. COMT Val108/158Met genotype counts and frequencies in male and female control 
subjects, patients with schizophrenia or alcohol dependence, further subdivided according to the 
smoking status into smokers and non-smokers. 
 COMT Val
108/158
Met genotype 
 Male subjects Female subjects 
 
Met/Met 
N (%) 
Val/Met 
N (%) 
Val/Val 
N (%) 
Met/Met 
N (%) 
Val/Met 
N (%) 
Val/Val 
N (%) 
Healthy control smokers 56 
(25.7) 
93 
(42.7) 
69
a
 
(31.6) 
15 
(22.4) 
39 
(55.2) 
15 
(22.4) 
Healthy control non-smokers 108 
(22.2) 
267 
(54.9) 
111 
(22.9) 
78 
(28.6) 
134 
(45.0) 
73 
(26.4) 
Smokers with schizophrenia 104 
(27.2) 
185 
(48.4) 
93 
(24.4) 
29 
(23.6) 
58 
(47.1) 
36 
(29.3) 
Non-smokers with schizophrenia 47 
(26.7) 
87 
(49.4) 
42 
(23.9) 
31 
(21.1) 
68 
(46.3) 
48 
(32.6) 
Smokers with alcoholism 75 
(24.9) 
154 
(51.2) 
72 
(23.9) 
23 
(33.8) 
30 
(44.1) 
15 
(22.1) 
Non-smokers with alcoholism 52 
(27.1) 
103 
(53.6) 
37 
(19.3) 
14 
(25.4) 
27 
(49.2) 
14 
(25.4) 
a
P = 0.008 vs. healthy male non-smokers (χ
2 
test).  
COMT: catechol-O-methyl transferase; Met: methonine; Val: valine; N: genotype count.   
 
